Dezerv

Fund Overview

Fund Size

Fund Size

₹60 Cr

Expense Ratio

Expense Ratio

1.21%

ISIN

ISIN

INF397L01LK4

Minimum SIP

Minimum SIP

₹500

Exit Load

Exit Load

1.00%

Inception Date

Inception Date

28 Feb 2019

About this fund

LIC MF Healthcare Fund Direct Growth is a Sector - Healthcare mutual fund schemes offered by LIC Mutual Fund. This fund has been in existence for 5 years, 4 months and 14 days, having been launched on 28-Feb-19.
As of 11-Jul-24, it has a Net Asset Value (NAV) of ₹27.76, Assets Under Management (AUM) of 60.38 Crores, and an expense ratio of 1.21%.
  • LIC MF Healthcare Fund Direct Growth has given a CAGR return of 20.96% since inception.
  • The fund's asset allocation comprises around 97.92% in equities, 0.00% in debts, and 2.08% in cash & cash equivalents.
  • You can start investing in LIC MF Healthcare Fund Direct Growth with a SIP of ₹500 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+44.27%

+45.19% (Cat Avg.)

3 Years

+11.45%

+14.31% (Cat Avg.)

5 Years

+23.10%

+25.82% (Cat Avg.)

Since Inception

+20.96%

(Cat Avg.)

Portfolio Summaryas of 30th June 2024

Equity59.13 Cr97.92%
Others1.25 Cr2.08%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Sun Pharmaceuticals Industries LtdEquity7.06 Cr11.37%
Piramal Pharma LtdEquity3.88 Cr6.25%
J.B. Chemicals & Pharmaceuticals LtdEquity3.69 Cr5.96%
Glenmark Pharmaceuticals LtdEquity3.66 Cr5.90%
Cipla LtdEquity3.6 Cr5.80%
Torrent Pharmaceuticals LtdEquity3.46 Cr5.58%
Mankind Pharma LtdEquity3.36 Cr5.41%
Dr Reddy's Laboratories LtdEquity3.27 Cr5.27%
Zydus Lifesciences LtdEquity3.09 Cr4.98%
Artemis Medicare Services Ltd Ordinary SharesEquity2.95 Cr4.76%
Apollo Hospitals Enterprise LtdEquity2.84 Cr4.58%
Abbott India LtdEquity2.83 Cr4.57%
Divi's Laboratories LtdEquity2.55 Cr4.11%
Ipca Laboratories LtdEquity2.42 Cr3.90%
Alkem Laboratories LtdEquity2.41 Cr3.89%
Global Health LtdEquity2.36 Cr3.80%
Laurus Labs LtdEquity2.09 Cr3.37%
Metropolis Healthcare LtdEquity1.55 Cr2.49%
Neogen Chemicals LtdEquity1.48 Cr2.39%
TrepsCash - Repurchase Agreement1.44 Cr2.32%
Suven Pharmaceuticals LtdEquity1.21 Cr1.95%
Syngene International LtdEquity0.98 Cr1.57%
Net Receivables / (Payables)Cash-0.15 Cr0.25%

Allocation By Market Cap (Equity)

Large Cap Stocks

42.13%

Mid Cap Stocks

24.81%

Small Cap Stocks

30.98%

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare59.27 Cr95.54%
Basic Materials1.48 Cr2.39%

Risk & Performance Ratios

Standard Deviation

This fund

14.28%

Cat. avg.

14.65%

Lower the better

Sharpe Ratio

This fund

0.38

Cat. avg.

0.55

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

0.92

Higher the better

Fund Managers

Karan Doshi

Karan Doshi

Since July 2023

Additional Scheme Detailsas of 30th June 2024

ISIN
INF397L01LK4
Expense Ratio
1.21%
Exit Load
1.00%
Fund Size
₹60 Cr
Age
28 Feb 2019
Lumpsum Minimum
₹5,000
Fund Status
Open Ended Investment Company
Benchmark
BSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Withdrawal within 1 year

Flat 15% tax on realised gains (STCG - short term capital gains)

Withdrawal after 1 year

10% tax on realised gains above Rs. 1 lakh per financial year (LTCG - long term capital gains)

Note: Mutual funds are subject to capital gains taxation with surcharge and cess, based on prevailing income tax rules and investor income. Taxation applies to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Motilal Oswal S&P BSE Healthcare ETF

Very High Risk

0.2%-₹13.07 Cr47.0%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Very High Risk

1.0%1.0%₹713.42 Cr48.3%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹713.42 Cr46.2%
Aditya Birla Sun Life Nifty Healthcare ETF

Very High Risk

0.2%-₹29.73 Cr45.3%
ITI Pharma and Healthcare Fund Direct Growth

Very High Risk

0.4%1.0%₹166.33 Cr43.7%
ITI Pharma and Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹166.33 Cr40.9%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2312.48 Cr46.8%
Mirae Asset Healthcare Fund Regular Growth

Very High Risk

2.0%1.0%₹2312.48 Cr44.6%
Nippon India Nifty Pharma ETF

Very High Risk

0.2%-₹638.88 Cr48.8%
Axis NIFTY Healthcare ETF

Very High Risk

0.3%-₹17.23 Cr44.2%

About the AMC

LIC Mutual Fund

LIC Mutual Fund

Total AUM

₹1,285 Cr

Address

4th Floor, Industrial Assurance Building, Mumbai, 400 020

Other Funds by LIC Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
LIC MF Gold ETF FOF Direct Growth

High Risk

0.3%1.0%₹54.11 Cr23.5%
LIC MF Equity Savings Fund Direct Growth

Moderately High risk

1.0%1.0%₹16.24 Cr17.7%
LIC MF Nifty Next 50 Index Fund Direct Growth

Very High Risk

0.3%0.0%₹84.08 Cr67.9%
LIC MF Focused 30 Equity Direct Growth

Very High Risk

1.6%1.0%₹130.71 Cr28.4%
LIC MF Long Term Value Fund Direct Growth

Very High Risk

1.6%1.0%₹111.60 Cr44.2%
LIC MF Healthcare Fund Direct Growth

Very High Risk

1.2%1.0%₹60.38 Cr44.3%
LIC MF Small Cap Fund Direct Growth

Very High Risk

1.5%1.0%₹237.22 Cr59.9%
LIC MF Midcap Fund Direct Growth

Very High Risk

1.6%1.0%₹272.73 Cr61.3%
LIC MF Dividend Yield Fund Direct Growth

Very High Risk

1.4%1.0%₹189.29 Cr61.3%

Risk Level

Your principal amount will be at Very High Risk

Very High Risk
Wealth Monitor

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

The NAV of LIC MF Healthcare Fund Direct Growth, as of 11-Jul-2024, is ₹27.76.
The fund has generated 44.27% over the last 1 year and 11.45% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.
The fund's allocation of assets is distributed as 97.92% in equities, 0.00% in bonds, and 2.08% in cash and cash equivalents.
The fund managers responsible for LIC MF Healthcare Fund Direct Growth are:-
  1. Karan Doshi